Titre:3rd global pharma conference | pharmaceutical congress uk
La description :ipharma uk conference is the only interactive, peer-led conference and expo in europe for pharma professionals to be held at london, uk during july 2019...
Classement Alexa Global: # 5,645,204
Server:Apache...
L'adresse IP principale: 46.105.40.12,Votre serveur France,Roubaix
ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 17-Aug-2018
Created Date:
2016-12-19
Changed Date:
2017-12-24
Données techniques du ipharmaconference.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte ipharmaconference.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 0, mail exchanger = ipharmaconference.com.
HtmlToText
-- july 03-05, 2019 london, uk download brochure sponsor exhibit register to attend -- download brochure sponsor exhibit register to attend download brochure sponsor exhibit register to attend --- toggle navigation home program conference sessions tentative program committee organizing committee scientific committee submit abstract exhibit & sponsor registration venue contact us are you interested in reaching all of these audiences? book a package of meetings or join the agenda. arrange meetings with healthcare group leaders and investors join now -- previous next about conference 3 rd global pharmaceutical conference and expo welcomes you as our guest to the city of london, uk during july 03-05, 2019. the theme of the upcoming edition of i-pharma uk is emerging trends in pharma research towards global demand . the annual ipharma conference and expo is the largest gathering of pharma and healthcare professionals in uk and in europe. i-pharma uk is expecting hundreds of academic, research and industry leaders from 24 different countries to gather in london, uk for this three day meeting. i-pharma congress is packed with many workshops, symposiums and multiple plenary sessions with main focus on thought provoking discussions and peer led networking. the conference is the ideal venue for to learn about the latest trends shaping the pharma industry, to gain new skills and insights from successful pharma experts. for i-pharma uk, renowned academic, researchers along with industry leaders from key pharma companies will be sharing their insights into the role of drug discovery, drug designing, drug development, digital pharma, pharmacovigilance, pharma packaging, biopharmaceuticals, drug delivery systems and translating this into real life strategies for your career and business. i-pharma uk 2019 offers unparalleled business, research opportunities and access to new markets in pharma and health care industry. be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest. join us and witness the booming industry by participating at i-pharma uk 2019 and give your career and business access to new opportunities from throughout the world. international pharma conference and conference welcomes you as our guest to the city of skyscrapers- dubai, uae during november 15-16, 2017. in today's era, where health is a dynamic process, we aims to make a healthy today for a healthier tomorrow at ipharma 2017 . international pharma conference and conference (ipharma 2017) includes nearly every permutation of knowledge, innovation, technology and networking; and has an objective of creating an international forum for academicians, practitioners and business professionals to sharpen their saw and discuss the soundest issues related to pharmaceuticals. ipce 2017 offers unparalleled business opportunities and access to new markets in health science. the exhilarating program is going to have presentations on most ingenious, modernistic and recent research activities. be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest and may lead to a change in your career and business, while forming new relationships, and strengthen existing ones. when you leave dubai, we assure you that you will be able to use newly acquired information straight away at the bench or at the bedside. join us and witness the booming market by participating at ipharma 2017 and give your business access to buyers and opportunities from throughout the world.-- target audience researchers, scientists & biotechnology experts pharmaceutical & biotechnology companies healthcare departments clinicians & paramedical professionals key decision makers government heads & officials researchers, scientists & biotechnology experts pharmaceutical & biotechnology companies healthcare departments clinicians & paramedical professionals key decision makers government heads & officials highlights drug discovery & designing innovations in drug development novel drug delivery systems pharmacovigilance & clinical trials biosimilars & orphan drugs biopharmaceuticals & nutraceuticals digital pharma & marketing pharmaceutical manufacturing. drug discovery & designing innovations in drug development novel drug delivery systems pharmacovigilance & clinical trials biosimilars & orphan drugs biopharmaceuticals & nutraceuticals digital pharma & marketing pharmaceutical manufacturing. why ipharma uk interactive panel sessions- our sessions are 100% interactive case study driven- expect real-life examples and shared experience peer discussions- practical processes you can take away and implement. get the latest updates from hard-to-reach experts share your products and services. interactive panel sessions- our sessions are 100% interactive case study driven- expect real-life examples and shared experience peer discussions- practical processes you can take away and implement. get the latest updates from hard-to-reach experts share your products and services. featured speakers myra weiner president toxpertise, llc usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- prof. ye xu dean jilin medical university china eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- nigel smart president smart pharmaceutical consulting usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- amala kompella natco pharmaceuticals india eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- giuseppe santo angelini italy eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- sanju nanda m.d.university india eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- taosheng chen st. jude children's research hospital usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- mark feitelson temple university usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- kate peng genentech usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- elizabeth whalley buono hancock, daniel & johnson usa eric brody managing director middle east joint commission international uae andrea willson managing director middle east joint commission international uae john cornick managing director middle east joint commission international uae -- sunil premawansa rangsit university
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR BigRock Solutions Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =ipharmaconference.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME ipharmaconference.com
CHANGED 2017-12-24
CREATED 2016-12-19
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
ipharmaconference.com rapport :
Visitez le site